Key Market Segments:
By Treatment
- 
	
Injectable Antipsychotics
 - 
	
Oral Antipsychotics
 
By Class
- 
	
Second-Generation Antipsychotics
- 
		
Risperdal (Risperidone)
 - 
		
Seroquel (Quetiapine)
 - 
		
Invega (Paliperidone)
 - 
		
Geodon (Ziprasidone)
 - 
		
Latuda (Lurasidone)
 - 
		
Saphris (Asenapine)
 - 
		
Aristada (Aripiprazole Lauroxil)
 - 
		
Fanapt (Iloperidone)
 - 
		
Zyprexa (Olanzapine)
 - 
		
Vraylar (Cariprazine)
 
 - 
		
 - 
	
Third-Generation Antipsychotics
- 
		
Abilify (Aripiprazole)
 
 - 
		
 - 
	
Others
- 
		
First-Generation Antipsychotics
 - 
		
Generics
 
 - 
		
 
By Distribution Channel
- 
	
Online Pharmacies
 - 
	
Hospital Pharmacies
 - 
	
Retail Pharmacies
 - 
	
Others
 
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- 
	
US
 - 
	
Canada
 - 
	
Mexico
 
Europe
- 
	
Germany
 - 
	
France
 - 
	
UK
 - 
	
Italy
 - 
	
Spain
 - 
	
Poland
 - 
	
Turkey
 - 
	
Rest of Europe
 
Asia Pacific
- 
	
China
 - 
	
India
 - 
	
Japan
 - 
	
South Korea
 - 
	
Singapore
 - 
	
Australia
 - 
	
Rest of Asia Pacific
 
Middle East & Africa
- 
	
UAE
 - 
	
Saudi Arabia
 - 
	
Qatar
 - 
	
South Africa
 - 
	
Rest of Middle East & Africa
 
Latin America
- 
	
Brazil
 - 
	
Argentina
 - 
	
Rest of Latin America
 
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- 
	
Detailed Volume Analysis
 
- 
	
Criss-Cross segment analysis (e.g. Product X Application)
 
- 
	
Competitive Product Benchmarking
 
- 
	
Geographic Analysis
 
- 
	
Additional countries in any of the regions
 
- 
	
Customized Data Representation
 
- 
	
Detailed analysis and profiling of additional market players